The #FDA has extended its review of #Novo's experimental #haemophiliaA drug #denecimig because of ongoing remediation work at a facility that will be used to manufacture the #FactorVIIIamimetic.
@pharmaphorum.bsky.social
@pharmaphorum.bsky.social
@pharmaphorum.bsky.socialThe #FDA has extended its review of #Novo's experimental #haemophiliaA drug #denecimig because of ongoing remediation work at a facility that will be used to manufacture the #FactorVIIIamimetic.